In murine models of MS, total ablation of Lcn2 (Lcn2 KO) ameliorates EAE-related symptoms, suggesting that LCN2 expression in spinal cord and peripheral immune organs contribute to EAE development [18]. The gene discussed is LCN2; the disease is myeloid sarcoma.